Form 10-Q Teladoc, Inc. For: Jun 30

Go back to Form 10-Q Teladoc, Inc. For: Jun 30

Teladoc (TDOC) PT Raised to $86 at Chardan Capital Markets

August 3, 2018 6:39 AM EDT

Chardan Capital Markets raised its price target on Teladoc (NYSE: TDOC) to $86.00 (from $73.00) while maintaining a Buy rating.

Analyst Steven Wardell commented, "After market close on Wed., TDOC reported revenue and earnings that beat "consensus, and raised its 2018 guide. TDOCs... More

Teladoc (TDOC) PT Raised to $68 at Oppenheimer

August 2, 2018 9:32 AM EDT

Oppenheimer raised its price target on Teladoc (NYSE: TDOC) to $68.00 (from $59.00) while maintaining a Outperform rating.

Analyst Mohan Naidu commented, "Teladoc Health (as the company has renamed itself) beat our and consensus expectations for revenues and EBITDA at $95M/$2.7M... More